📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-27 19:49
45 analysed today
FollowTelegram
45
Today
149,996
All-time analysed
42,997
Positive
6,670
Negative
91,612
Neutral
8,649
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
4 announcements match the current filters (relevance ≥ 5).
Add-Shop ERetail Submits FY26 Annual Report; Seeks Approval for Rs 500 Cr in RPT Limits
Add-Shop E-Retail Limited has submitted its Annual Report for FY26 and scheduled its 13th Annual General Meeting for September 19, 2026. Key special resolutions include shareholder approval for material related party transactions of up to Rs 250.00 Crore each with Dada Organics Limited and Dadaji Lifescience Private Limited. In aggregate, the proposed Rs 500 Crore RPT limits significantly exceed the company's TTM revenue of Rs 171 Crore and FY26 annual revenue of Rs 154.65 Crore.
Confidence: HIGH
What changedAdd-Shop E-Retail filed its FY26 Integrated Annual Report and issued the formal notice convening its 13th AGM.
Why it mattersThe company is seeking substantial related-party transaction limits that dwarf its existing annual top line and market capitalization, warranting corporate governance monitoring.
AGM Date: 19th September, 2026RPT Limit - Dada Organics Ltd: Rs. 250.00 CroreRPT Limit - Dadaji Lifescience Pvt Ltd: Rs. 250.00 CroreCombined RPT vs TTM Revenue: ~292%
📅 Short termAdministrative filing ahead of the AGM; shareholder scrutiny on large RPT approvals is expected.
📈 Long termSubstantial reliance on related-party transactions poses governance and margin dependency questions for minority shareholders.
⚠ Risk flags
- High related-party transaction limits (Rs 500 Cr total) relative to small operating revenue (Rs 154.65 Cr in FY26)
- Low promoter holding at 27.2%
Key Highlights
13th AGM scheduled for Saturday, 19th September, 2026 at 4:00 PM via Video Conferencing.
Shareholder approval sought for material related party transactions with M/s Dada Organics Limited up to Rs 250.00 Crore.
Shareholder approval sought for material related party transactions with M/s Dadaji Lifescience Private Limited up to Rs 250.00 Crore.
Total RPT approvals sought (Rs 500 Crore) stand at ~2.9x the company's TTM revenue of Rs 171 Crore.
👀 What to Watch
Track shareholder voting outcomes for the AGM resolutions on September 19, 2026, especially regarding related-party transaction authorizations.
Add-Shop ERetail Q1 FY27 Revenue Grows 55% YoY to ₹45.64 Cr; PAT at ₹0.27 Cr
Add-Shop ERetail reported a 55% YoY increase in revenue to ₹45.64 Cr for Q1 FY27, though this represents a 20% sequential decline from Q4 FY26. Net profit grew 28% YoY to ₹0.27 Cr, but fell 25% compared to the previous quarter's ₹0.36 Cr. The Animal Food segment continues to dominate the business, contributing 79% of total revenue. Despite the top-line growth, the company operates on extremely thin margins, with a quarterly PAT margin of just 0.58%.
Confidence: HIGH
What changedThe company released its unaudited financial results for the first quarter of FY27, showing strong year-on-year growth but a sequential slowdown in both revenue and profit.
Why it mattersFor a micro-cap company with a ₹19 Cr market cap, maintaining revenue growth is critical, but the extremely low operating margins (TTM OPM 2.1%) leave very little room for error or cost increases.
Revenue (Q1 FY27): ₹45.64 CrNet Profit (Q1 FY27): ₹0.27 CrAnimal Food Revenue: ₹36.03 CrRevenue vs TTM Revenue: 29.4%Unallocable Segment Loss: ₹9.89 Cr
📅 Short termThe stock may see neutral to slightly positive sentiment due to YoY growth, but the sequential decline and thin margins are likely to limit any major upside.
📈 Long termThe company's long-term viability depends on scaling its high-margin segments like Ayurvedic products and improving overall operational efficiency to move beyond its current 2% margin profile.
⚠ Risk flags
- Extremely thin net profit margins (under 1%)
- High segment concentration (Animal Food)
- Significant unallocable losses impacting consolidated results
Key Highlights
Revenue from operations increased to ₹45.64 Cr in Q1 FY27 from ₹29.41 Cr in Q1 FY26.
Net profit for the quarter stood at ₹26.69 Lakhs (₹0.27 Cr) against ₹20.95 Lakhs YoY.
Animal Food segment revenue reached ₹36.03 Cr, accounting for 79% of total quarterly sales.
Unallocable segment reported a significant loss of ₹9.89 Cr at the result level, dragging down overall profitability.
Basic and Diluted EPS for the quarter remained low at ₹0.09.
👀 What to Watch
Investors should monitor the company's ability to control 'Unallocable' expenses, which significantly impact the bottom line, and watch for any margin improvement in the core Animal Food segment.
Q1 Net Profit up 27% YoY to ₹0.27 Cr; Revenue grows 55% YoY to ₹45.64 Cr
Add-Shop ERetail reported a 55.2% YoY increase in revenue to ₹45.64 Cr for Q1 FY27, though revenue declined 19.9% sequentially from Q4 FY26 (₹56.99 Cr). Net profit rose 27.4% YoY to ₹0.27 Cr, but fell 26% on a quarter-on-quarter basis. The Animal Food segment remains the primary revenue driver, contributing approximately 79% of total turnover. Despite the growth in scale, the company continues to operate with extremely thin net margins of approximately 0.58%.
Confidence: HIGH
What changedThe company reported its Q1 FY27 results showing strong annual growth but a sequential slowdown in both revenue and profit compared to the March 2026 quarter.
Why it mattersFor a micro-cap company with a ₹19 Cr market cap, maintaining high revenue volume is essential for survival, but the high concentration in the Animal Food segment and low margins pose structural risks.
Revenue (Q1 FY27): ₹4,563.89 LakhsNet Profit (Q1 FY27): ₹26.69 LakhsAnimal Food Segment Revenue: ₹3,603.32 LakhsQ1 Revenue vs TTM Revenue: ~29.4%Net Profit Margin: 0.58%
📅 Short termThe stock may see neutral to slightly negative sentiment due to the sequential decline in profit and revenue despite the YoY growth.
📈 Long termThe long-term outlook depends on the company's ability to diversify its revenue streams beyond animal food and improve its operating leverage to boost margins.
⚠ Risk flags
- Extremely low net profit margins
- High segment concentration (Animal Food)
- Sequential decline in financial performance
Key Highlights
Revenue from operations increased to ₹4,563.89 Lakhs (₹45.64 Cr) from ₹2,941.22 Lakhs in the same quarter last year.
Net profit for the quarter stood at ₹26.69 Lakhs, up from ₹20.95 Lakhs in Q1 FY26.
Animal Food segment revenue dominated the mix at ₹3,603.32 Lakhs, accounting for 78.9% of total revenue.
Total expenses rose significantly to ₹4,528.20 Lakhs, driven primarily by Purchase of Stock-in-Trade at ₹3,553.56 Lakhs.
Earnings per share (EPS) for the quarter was ₹0.09, compared to ₹0.13 in the preceding quarter.
👀 What to Watch
Investors should monitor if the company can translate its revenue growth into better margins, as current profitability remains very low relative to the ₹45 Cr+ quarterly turnover.
Add-Shop ERetail Q1 FY27: Revenue Grows 55% YoY to ₹45.64 Cr; Net Profit at ₹0.27 Cr
Add-Shop ERetail reported a 55.2% YoY increase in revenue to ₹45.64 Cr for the quarter ended June 30, 2026. However, on a sequential basis, revenue declined by 19.9% from ₹56.99 Cr in Q4 FY26. Net profit followed a similar trend, growing 28.6% YoY to ₹0.27 Cr but falling 25% from the previous quarter. The company continues to operate on razor-thin margins, with a Profit Before Tax (PBT) of only ₹0.36 Cr on a ₹45.64 Cr revenue base.
Confidence: HIGH
What changedThe company has released its Q1 FY27 financial results, showing strong year-on-year growth but a sequential slowdown in business activity.
Why it mattersFor a micro-cap company with a market capitalization of only ₹19 Cr, the high revenue-to-market-cap ratio is notable, but the extremely low profitability (₹1 Cr TTM PAT) makes it highly sensitive to small changes in operating costs.
Revenue (Q1 FY27): ₹45.64 CrYoY Revenue Growth: 55.2%Net Profit (Q1 FY27): ₹0.27 CrAnimal Food Segment Revenue: ₹36.03 CrPBT Margin: 0.78%Market Cap to TTM Revenue: 0.12x
📅 Short termThe sequential decline in revenue and profit may lead to muted stock performance in the near term, despite the strong YoY growth figures.
📈 Long termThe company's long-term viability depends on its ability to scale the higher-margin Ayurvedic segment and control unallocable corporate overheads.
⚠ Risk flags
- Extremely thin operating margins
- High unallocable segment losses
- Micro-cap liquidity risk
- Sequential decline in top and bottom lines
Key Highlights
Revenue from operations increased 55.2% YoY to ₹45.64 Cr from ₹29.41 Cr.
Net profit rose to ₹0.27 Cr compared to ₹0.21 Cr in the year-ago period.
Animal Food segment remains the dominant revenue driver, contributing ₹36.03 Cr or 79% of total revenue.
Unallocable segment expenses/losses of ₹9.89 Cr significantly weighed down the operational profits of other segments.
Earnings Per Share (EPS) for the quarter stood at ₹0.09, down from ₹0.13 in the preceding quarter.
👀 What to Watch
Investors should monitor the 'Unallocable' segment costs, which are extremely high relative to the company's net profit. The key to a re-rating will be whether the company can improve its operating margins, which currently sit at a precarious ~2%.
